Search Results - "Heiati, Hashem"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Formulation and characterization of a ten-peptide single-vial vaccine EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy

    Formulation and characterization of a ten-peptide single-vial vaccine EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy by Beebe, Melanie, Qin, Mingsheng, Moi, Michael, Wu, Sharon, Heiati, Hashem, Walker, Les, Newman, Mark, Fikes, John, Ishioka, Glenn Y.

    Published in Human vaccines (01-05-2008)
    “…Effective vaccines that mediate clinical responses in cancer patients may require generation of broadly specific cytotoxic T lymphocytes (CTL) directed against…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate

    Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate by Heiati, Hashem, Tawashi, Rashad, Shivers, Richard R., Phillips, Nigel C.

    “…Solid lipid nanoparticles (SLN) were prepared with trilaurin (TL) as the SLN solid core and dipalmitoylphosphatidylcholine (DPPC) or a mixture of DPPC and…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Reversible lipidization for the oral delivery of salmon calcitonin

    Reversible lipidization for the oral delivery of salmon calcitonin by Wang, Jeff, Chow, Donald, Heiati, Hashem, Shen, Wei-Chiang

    Published in Journal of controlled release (26-03-2003)
    “…Salmon calcitonin (sCT), a 32-amino-acid polypeptide, was lipidized by using a reversible aqueous lipidization (REAL) technology. When injected subcutaneously…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice

    Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice by Heiati, Hashem, Tawashi, Rashad, Phillips, Nigel C

    Published in International journal of pharmaceutics (15-11-1998)
    “…Solid lipid nanoparticles (SLNs) were prepared using trilaurin as the SLNs solid core and a mixture of neutral and negatively charged phospholipid. To produce…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride

    Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride by HEIATI, H, PHILLIPS, N. C, TAWASHI, R

    Published in Pharmaceutical research (01-09-1996)
    “…Solid lipid nanoparticles (SLN) are comprised of a high-melting point triglyceride (TG) core with a phospholipid (PL) coating. This study has investigated the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Solid lipid nanoparticles as drug carriers

    Solid lipid nanoparticles as drug carriers by Heiati, Hashem, Tawashi, Rashad, Phillips, Nigel C

    Published in International journal of pharmaceutics (01-11-1998)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: